MedPath

A comparative study comparing anxiety reducing effect of tablet Lorazepam and tablet Alprazolam.

Phase 3
Conditions
Health Condition 1: K829- Disease of gallbladder, unspecified
Registration Number
CTRI/2024/05/066874
Lead Sponsor
Sanjay Gandhi Post Graduate Institute of Medical sciences Lucknow Uttar pradesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient giving written consent.

2.Patients belonging to ASA grade I and II.

3.All genders

4.Normal BMI(18.5-25) subjects.

5.Patients in the age group (18-60years) undergoing elective laparoscopic cholecystectomy.

Exclusion Criteria

1. Patients not giving consent.

2. ASA grade III and IV.

3. Emergency surgeries.

4. Patient who had taken analgesic, sedative, antidepressant, and on antiepileptic drugs were excluded.

6. Patients with psychiatry illness will be excluded.

5. Patients with anticipated difficult airway.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Objective – <br/ ><br>1.Comparison of Alprazolam and Lorazepam in terms of anxiolysis by Hamilton anxiety rating scale (HAM-A). <br/ ><br>2. Comparison of level of amnesia by MMSE score at time T1 and T2. <br/ ><br>Timepoint: At the time of giving premedication in the ward 3 hours prior to GA (T1), in the preoperative ward before shifting the patient to the operation theatre (T2)
Secondary Outcome Measures
NameTimeMethod
Secondary objectives – (i)Comparison of level of sedation by using Ramsey sedation score at time T1 & T2Timepoint: At the time of giving premedication in the ward 3 hours prior to GA (T1), in the preoperative ward before shifting the patient to the operation theatre (T2) <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath